WKN: | 858560 |
ISIN: | US5324571083 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Eli Lilly-Aktie
ein AAA-Rating hat,
erfahren Sie im Performance-Check
vom 02. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1997 | 31,24 | 64,01 | 104,90% |
2 | 2021 | 135,14 | 245,80 | 81,89% |
3 | 1995 | 12,94 | 20,58 | 59,04% |
4 | 2023 | 342,00 | 526,50 | 53,95% |
5 | 2014 | 37,47 | 57,64 | 53,83% |
6 | 1996 | 20,58 | 31,24 | 51,80% |
7 | 2000 | 67,50 | 99,00 | 46,67% |
8 | 2024 | 526,50 | 747,30 | 41,94% |
9 | 2022 | 245,80 | 342,00 | 39,14% |
10 | 2018 | 71,40 | 99,00 | 38,66% |
11 | 2015 | 57,64 | 79,70 | 38,27% |
12 | 2011 | 26,69 | 32,06 | 20,12% |
13 | 2019 | 99,00 | 117,26 | 18,44% |
14 | 1998 | 64,01 | 75,67 | 18,22% |
15 | 2005 | 41,63 | 48,19 | 15,76% |
16 | 2020 | 117,26 | 135,14 | 15,25% |
17 | 2012 | 32,06 | 36,72 | 14,54% |
18 | 2010 | 24,99 | 26,69 | 6,80% |
19 | 1993 | 12,85 | 13,23 | 2,96% |
20 | 2013 | 36,72 | 37,47 | 2,04% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 89,00 | 59,00 | -33,71% |
2 | 2004 | 57,00 | 41,63 | -26,96% |
3 | 2008 | 36,93 | 27,41 | -25,78% |
4 | 1992 | 16,49 | 12,85 | -22,07% |
5 | 2006 | 48,19 | 39,34 | -18,36% |
6 | 2025 | 747,30 | 625,60 | -16,29% |
7 | 2016 | 79,70 | 70,36 | -11,72% |
8 | 1999 | 75,67 | 67,50 | -10,80% |
9 | 2001 | 99,00 | 89,00 | -10,10% |
10 | 2009 | 27,41 | 24,99 | -8,83% |
11 | 2007 | 39,34 | 36,93 | -6,13% |
12 | 2003 | 59,00 | 57,00 | -3,39% |
13 | 1994 | 13,23 | 12,94 | -2,19% |
14 | 2017 | 70,36 | 71,40 | 1,48% |
15 | 2013 | 36,72 | 37,47 | 2,04% |
16 | 1993 | 12,85 | 13,23 | 2,96% |
17 | 2010 | 24,99 | 26,69 | 6,80% |
18 | 2012 | 32,06 | 36,72 | 14,54% |
19 | 2020 | 117,26 | 135,14 | 15,25% |
20 | 2005 | 41,63 | 48,19 | 15,76% |